메뉴 건너뛰기




Volumn 5, Issue , 2008, Pages

Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; LYSOPHOSPHATIDYLCHOLINE; PALMITIC ACID; PALMITOYLLYSOLECITHIN; PHOSPHOLIPASE A2; STEARIC ACID DERIVATIVE; STEAROYLLYSOPHOSPHATIDYLCHOLINE; UNCLASSIFIED DRUG;

EID: 55649115984     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-5-17     Document Type: Article
Times cited : (57)

References (63)
  • 2
    • 33750952878 scopus 로고    scopus 로고
    • Activation of human inflammatory cells by secreted phospholipases A2
    • 16952481
    • Activation of human inflammatory cells by secreted phospholipases A2. M Triggiani F Granata A Frattini G Marone, Biochim Biophys Acta 2006 1761 1289 1300 16952481
    • (2006) Biochim Biophys Acta , vol.1761 , pp. 1289-1300
    • Triggiani, M.1    Granata, F.2    Frattini, A.3    Marone, G.4
  • 3
    • 27644566534 scopus 로고    scopus 로고
    • Secretory phospholipases A2 in inflammatory and allergic diseases: Not just enzymes
    • 10.1016/j.jaci.2005.08.011. 16275367
    • Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. M Triggiani F Granata G Giannattasio G Marone, J Allergy Clin Immunol 2005 116 1000 1006 10.1016/j.jaci.2005.08.011 16275367
    • (2005) J Allergy Clin Immunol , vol.116 , pp. 1000-1006
    • Triggiani, M.1    Granata, F.2    Giannattasio, G.3    Marone, G.4
  • 4
    • 0029662071 scopus 로고    scopus 로고
    • Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients
    • 8823686
    • Secretory phospholipase A2 as an index of disease activity in rheumatoid arthritis. Prospective double blind study of 212 patients. MK Lin V Farewell P Vadas AA Bookman EC Keystone W Pruzanski, J Rheumatol 1996 23 1162 1166 8823686
    • (1996) J Rheumatol , vol.23 , pp. 1162-1166
    • Lin, M.K.1    Farewell, V.2    Vadas, P.3    Bookman, A.A.4    Keystone, E.C.5    Pruzanski, W.6
  • 5
    • 8744226866 scopus 로고    scopus 로고
    • Systemic treatment of cerebral cortex lesions in rats with a new secreted phospholipase A2 inhibitor
    • 10.1089/neu.2004.21.1683. 15684658
    • Systemic treatment of cerebral cortex lesions in rats with a new secreted phospholipase A2 inhibitor. TJ Cunningham N Souayah B Jameson J Mitchell L Yao, J Neurotrauma 2004 21 1683 1691 10.1089/neu.2004.21.1683 15684658
    • (2004) J Neurotrauma , vol.21 , pp. 1683-1691
    • Cunningham, T.J.1    Souayah, N.2    Jameson, B.3    Mitchell, J.4    Yao, L.5
  • 6
    • 33750047832 scopus 로고    scopus 로고
    • Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis
    • 16965627. 10.1186/1742-2094-3-26
    • Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis. TJ Cunningham L Yao M Oetinger L Cort EP Blankenhorn JI Greenstein, J Neuroinflammation 2006 3 26 16965627 10.1186/1742-2094-3-26
    • (2006) J Neuroinflammation , vol.3 , pp. 26
    • Cunningham, T.J.1    Yao, L.2    Oetinger, M.3    Cort, L.4    Blankenhorn, E.P.5    Greenstein, J.I.6
  • 7
    • 17944399890 scopus 로고    scopus 로고
    • Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris
    • 10.1016/S0002-9149(00)01069-9. 11018189
    • Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris. K Kugiyama Y Ota S Sugiyama H Kawano H Doi H Soejima S Miyamoto H Ogawa K Takazoe H Yasue, Am J Cardiol 2000 86 718 722 10.1016/S0002-9149(00)01069-9 11018189
    • (2000) Am J Cardiol , vol.86 , pp. 718-722
    • Kugiyama, K.1    Ota, Y.2    Sugiyama, S.3    Kawano, H.4    Doi, H.5    Soejima, H.6    Miyamoto, S.7    Ogawa, H.8    Takazoe, K.9    Yasue, H.10
  • 10
    • 0037131329 scopus 로고    scopus 로고
    • Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: Implications for the inflammatory response in atherogenesis
    • 10.1161/01.RES.0000038341.34243.64. 12386144
    • Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling: implications for the inflammatory response in atherogenesis. L Fuentes M Hernandez FJ Fernandez-Aviles MS Crespo ML Nieto, Circ Res 2002 91 681 688 10.1161/01.RES.0000038341.34243.64 12386144
    • (2002) Circ Res , vol.91 , pp. 681-688
    • Fuentes, L.1    Hernandez, M.2    Fernandez-Aviles, F.J.3    Crespo, M.S.4    Nieto, M.L.5
  • 11
    • 0029033619 scopus 로고
    • Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells
    • 7540278
    • Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. M Jaattela M Benedict M Tewari JA Shayman VM Dixit, Oncogene 1995 10 2297 2305 7540278
    • (1995) Oncogene , vol.10 , pp. 2297-2305
    • Jaattela, M.1    Benedict, M.2    Tewari, M.3    Shayman, J.A.4    Dixit, V.M.5
  • 12
    • 0028802503 scopus 로고
    • Mediators of injury in neurotrauma: Intracellular signal transduction and gene expression
    • 8594208
    • Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. NG Bazan EB Rodriguez de Turco G Allan, J Neurotrauma 1995 12 791 814 8594208
    • (1995) J Neurotrauma , vol.12 , pp. 791-814
    • Bazan, N.G.1    Rodriguez De Turco, E.B.2    Allan, G.3
  • 13
    • 0036669210 scopus 로고    scopus 로고
    • Phospholipase A2 enzymes
    • 10.1016/S0090-6980(02)00020-5
    • Phospholipase A2 enzymes. I Kudo M Murakami, Prostaglandins Other Lipid Mediat 2002 68-69 3 58 10.1016/S0090-6980(02)00020-5
    • (2002) Prostaglandins Other Lipid Mediat , vol.68-69 , pp. 3-58
    • Kudo, I.1    Murakami, M.2
  • 15
    • 55649088739 scopus 로고    scopus 로고
    • 128 Decreased lysophosphatidylcholine levels are associated with sepsis compared to uninfected inflammation prior to onset of sepsis
    • 10.1016/j.jss.2006.12.141
    • 128 Decreased lysophosphatidylcholine levels are associated with sepsis compared to uninfected inflammation prior to onset of sepsis. E Lissauer B Johnson S Shi T Gentle M Scalea, Journal of Surgical Research 2007 137 206 206 10.1016/j.jss.2006.12.141
    • (2007) Journal of Surgical Research , vol.137 , pp. 206-206
    • Lissauer, E.1    Johnson, B.2    Shi, S.3    Gentle, T.4    Scalea, M.5
  • 16
    • 0142074218 scopus 로고    scopus 로고
    • Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients
    • 10.1194/jlr.M200401-JLR200
    • Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. W Drobnik, The Journal of Lipid Research 2003 44 754 761 10.1194/jlr.M200401-JLR200
    • (2003) The Journal of Lipid Research , vol.44 , pp. 754-761
    • Drobnik, W.1
  • 17
    • 33746048017 scopus 로고    scopus 로고
    • Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of Gram-negative and Gram-positive shock
    • 16751791. 10.1038/sj.bjp.0706788
    • Lysophosphatidylcholine reduces the organ injury and dysfunction in rodent models of Gram-negative and Gram-positive shock. O Murch M Collin B Sepodes SJ Foster H Mota-Filipe C Thiemermann, British Journal of Pharmacology 2006 148 769 777 16751791 10.1038/sj.bjp.0706788
    • (2006) British Journal of Pharmacology , vol.148 , pp. 769-777
    • Murch, O.1    Collin, M.2    Sepodes, B.3    Foster, S.J.4    Mota-Filipe, H.5    Thiemermann, C.6
  • 19
    • 21744439466 scopus 로고    scopus 로고
    • Suppression of HMGB 1 release by stearoyl lysophosphatidylcholine: An additional mechanism for its therapeutic effects in experimental sepsis
    • 10.1194/jlr.C400018-JLR200
    • Suppression of HMGB 1 release by stearoyl lysophosphatidylcholine: an additional mechanism for its therapeutic effects in experimental sepsis. G Chen, The Journal of Lipid Research 2005 46 623 627 10.1194/jlr.C400018-JLR200
    • (2005) The Journal of Lipid Research , vol.46 , pp. 623-627
    • Chen, G.1
  • 20
    • 21744439466 scopus 로고    scopus 로고
    • Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis
    • 10.1194/jlr.C400018-JLR200. 15687351
    • Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. G Chen J Li X Qiang CJ Czura M Ochani K Ochani L Ulloa H Yang KJ Tracey P Wang, J Lipid Res 2005 46 623 627 10.1194/jlr.C400018-JLR200 15687351
    • (2005) J Lipid Res , vol.46 , pp. 623-627
    • Chen, G.1    Li, J.2    Qiang, X.3    Czura, C.J.4    Ochani, M.5    Ochani, K.6    Ulloa, L.7    Yang, H.8    Tracey, K.J.9    Wang, P.10
  • 21
    • 0036303682 scopus 로고    scopus 로고
    • A Potent Protective Role of Lysophospholipids Against Global Cerebral Ischemia and Glutamate Excitotoxicity in Neuronal Cultures
    • 10.1097/00004647-200207000-00007. 12142567
    • A Potent Protective Role of Lysophospholipids Against Global Cerebral Ischemia and Glutamate Excitotoxicity in Neuronal Cultures. N Blondeau I Lauritzen C Widmann M Lazdunski C Heurteaux, J Cereb Blood Flow Metab 2002 22 821 834 10.1097/00004647-200207000-00007 12142567
    • (2002) J Cereb Blood Flow Metab , vol.22 , pp. 821-834
    • Blondeau, N.1    Lauritzen, I.2    Widmann, C.3    Lazdunski, M.4    Heurteaux, C.5
  • 22
    • 0035041072 scopus 로고    scopus 로고
    • An update on inhibitors of human 14 kDa Type II s-PLA2 in development
    • 10.2174/1381612013398275. 11311112
    • An update on inhibitors of human 14 kDa Type II s-PLA2 in development. DM Springer, Curr Pharm Des 2001 7 181 198 10.2174/1381612013398275 11311112
    • (2001) Curr Pharm des , vol.7 , pp. 181-198
    • Springer, D.M.1
  • 23
    • 33750043500 scopus 로고    scopus 로고
    • Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9
    • 16965626. 10.1186/1742-2094-3-25
    • Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9. TJ Cunningham J Maciejewski L Yao, J Neuroinflammation 2006 3 25 16965626 10.1186/1742-2094-3-25
    • (2006) J Neuroinflammation , vol.3 , pp. 25
    • Cunningham, T.J.1    MacIejewski, J.2    Yao, L.3
  • 24
    • 0344876134 scopus 로고    scopus 로고
    • Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation
    • 10.1002/glia.10296. 14603468
    • Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation. F Pinto T Brenner P Dan M Krimsky S Yedgar, Glia 2003 44 275 282 10.1002/glia.10296 14603468
    • (2003) Glia , vol.44 , pp. 275-282
    • Pinto, F.1    Brenner, T.2    Dan, P.3    Krimsky, M.4    Yedgar, S.5
  • 25
    • 33845995114 scopus 로고    scopus 로고
    • Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction
    • 10.1074/jbc.M607975200. 17008322
    • Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. M Ohtsuki Y Taketomi S Arata S Masuda Y Ishikawa T Ishii Y Takanezawa J Aoki H Arai K Yamamoto, J Biol Chem 2006 281 36420 36433 10.1074/jbc.M607975200 17008322
    • (2006) J Biol Chem , vol.281 , pp. 36420-36433
    • Ohtsuki, M.1    Taketomi, Y.2    Arata, S.3    Masuda, S.4    Ishikawa, Y.5    Ishii, T.6    Takanezawa, Y.7    Aoki, J.8    Arai, H.9    Yamamoto, K.10
  • 26
    • 0036061703 scopus 로고    scopus 로고
    • Human Secretory Phospholipase A2 Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice
    • 10.1161/01.ATV.0000023228.90866.29. 12117740
    • Human Secretory Phospholipase A2 Mediates Decreased Plasma Levels of HDL Cholesterol and ApoA-I in Response to Inflammation in Human ApoA-I Transgenic Mice. UJF Tietge C Maugeais S Lund-Katz D Grass FC deBeer DJ Rader, Arterioscler Thromb Vasc Biol 2002 22 7 1213 1218 10.1161/01.ATV.0000023228.90866.29 12117740
    • (2002) Arterioscler Thromb Vasc Biol , vol.22 , Issue.7 , pp. 1213-1218
    • Tietge, U.J.F.1    Maugeais, C.2    Lund-Katz, S.3    Grass, D.4    Debeer, F.C.5    Rader, D.J.6
  • 27
    • 0022404771 scopus 로고
    • Analysis of progress curves for a highly concentrated michaelian enzyme in the presence or absence of product inhibition
    • 4062893
    • Analysis of progress curves for a highly concentrated michaelian enzyme in the presence or absence of product inhibition. N Kellershohn M Laurent, Biochem J 1985 231 65 74 4062893
    • (1985) Biochem J , vol.231 , pp. 65-74
    • Kellershohn, N.1    Laurent, M.2
  • 30
    • 0019888164 scopus 로고
    • The kinetics of the phospholipase A2-catalyzed hydrolysis of Egg phosphatidylcholine in unilamellar vesicles. Product inhibition and its relief by serum albumin
    • 7240204
    • The kinetics of the phospholipase A2-catalyzed hydrolysis of Egg phosphatidylcholine in unilamellar vesicles. Product inhibition and its relief by serum albumin. JP Kupferberg S Yokoyama FJ Kezdy, Journal of Biological Chemistry 1981 256 6274 6281 7240204
    • (1981) Journal of Biological Chemistry , vol.256 , pp. 6274-6281
    • Kupferberg, J.P.1    Yokoyama, S.2    Kezdy, F.J.3
  • 31
    • 0022182544 scopus 로고
    • Activation, aggregation, and product inhibition of cobra venom phospholipase A2 and comparison with other phospholipases
    • 4030786
    • Activation, aggregation, and product inhibition of cobra venom phospholipase A2 and comparison with other phospholipases. A Pluckthun EA Dennis, Journal of Biological Chemistry 1985 260 11099 11106 4030786
    • (1985) Journal of Biological Chemistry , vol.260 , pp. 11099-11106
    • Pluckthun, A.1    Dennis, E.A.2
  • 32
    • 70449158340 scopus 로고
    • A Simple Method for the Isolation and Purification of Total Lipides from Animal Tissues
    • 13428781
    • A Simple Method for the Isolation and Purification of Total Lipides From Animal Tissues. J Folch M Lees GS Stanley, Journal of Biological Chemistry 1957 226 497 509 13428781
    • (1957) Journal of Biological Chemistry , vol.226 , pp. 497-509
    • Folch, J.1    Lees, M.2    Stanley, G.S.3
  • 33
    • 0019304939 scopus 로고
    • Colorimetric determination of phospholipids with ammonium ferrothiocyanate
    • 10.1016/0003-2697(80)90269-9. 6892980
    • Colorimetric determination of phospholipids with ammonium ferrothiocyanate. JCM Stewart, Anal Biochem 1980 104 10 14 10.1016/0003-2697(80) 90269-9 6892980
    • (1980) Anal Biochem , vol.104 , pp. 10-14
    • Stewart, J.C.M.1
  • 34
    • 0033957808 scopus 로고    scopus 로고
    • Simultaneous separation of lysophospholipids from the total lipid fraction of crude biological samples using two-dimensional thin-layer chromatography
    • 10627512
    • Simultaneous separation of lysophospholipids from the total lipid fraction of crude biological samples using two-dimensional thin-layer chromatography. K Yokoyama F Shimizu M Setaka, J Lipid Res 2000 41 1 142 147 10627512
    • (2000) J Lipid Res , vol.41 , Issue.1 , pp. 142-147
    • Yokoyama, K.1    Shimizu, F.2    Setaka, M.3
  • 35
    • 0021589194 scopus 로고
    • Comparison of two copper reagents for detection of saturated and unsaturated neutral lipids by charring-densitometry
    • 10.1080/01483918408067046
    • Comparison of two copper reagents for detection of saturated and unsaturated neutral lipids by charring-densitometry. CB Baron RF Coburn, J Liqu Chromatogr 1984 7 2793 2801 10.1080/01483918408067046
    • (1984) J Liqu Chromatogr , vol.7 , pp. 2793-2801
    • Baron, C.B.1    Coburn, R.F.2
  • 37
    • 0024593571 scopus 로고
    • A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin
    • 10.1016/0003-2697(89)90022-5. 2742139
    • A sensitive and continuous fluorometric assay for phospholipase A2 using pyrene-labeled phospholipids in the presence of serum albumin. F Radvanyi L Jordan F Russo-Marie C Bon, Anal Biochem 1989 177 103 109 10.1016/0003-2697(89) 90022-5 2742139
    • (1989) Anal Biochem , vol.177 , pp. 103-109
    • Radvanyi, F.1    Jordan, L.2    Russo-Marie, F.3    Bon, C.4
  • 39
    • 0033983832 scopus 로고    scopus 로고
    • Characterization of plasma unsaturated lysophosphatidylcholines in human and rat
    • 10600639. 10.1042/0264-6021:3450061
    • Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. M Croset N Brossard A Polette M Lagarde, Biochemical Journal 2000 345 61 10600639 10.1042/0264-6021:3450061
    • (2000) Biochemical Journal , vol.345 , pp. 61
    • Croset, M.1    Brossard, N.2    Polette, A.3    Lagarde, M.4
  • 40
    • 0021783983 scopus 로고
    • Reduction in plasma cholesterol and increase in biliary cholesterol by a diet rich in n-3 fatty acids in the rat
    • 4031646
    • Reduction in plasma cholesterol and increase in biliary cholesterol by a diet rich in n-3 fatty acids in the rat. S Balasubramaniam LA Simons S Chang JB Hickie, J Lipid Res 1985 26 6 684 689 4031646
    • (1985) J Lipid Res , vol.26 , Issue.6 , pp. 684-689
    • Balasubramaniam, S.1    Simons, L.A.2    Chang, S.3    Hickie, J.B.4
  • 41
    • 0014982515 scopus 로고
    • Exchange of phospholipid classes between liver microsomes and plasma: Comparison of rat, rabbit, and guinea pig
    • 5542703
    • Exchange of phospholipid classes between liver microsomes and plasma: comparison of rat, rabbit, and guinea pig. DB Zilversmit, J Lipid Res 1971 12 36 42 5542703
    • (1971) J Lipid Res , vol.12 , pp. 36-42
    • Zilversmit, D.B.1
  • 42
    • 0030976523 scopus 로고    scopus 로고
    • Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine (lysoPC) in ovarian cancer patients
    • 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4
    • Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine (lysoPC) in ovarian cancer patients. M Okita DC Gaudette GB Mills BJ Holub, International Journal of Cancer 1997 71 31 34 10.1002/(SICI)1097-0215(19970328)71:1<31::AID-IJC7>3.0.CO;2-4
    • (1997) International Journal of Cancer , vol.71 , pp. 31-34
    • Okita, M.1    Gaudette, D.C.2    Mills, G.B.3    Holub, B.J.4
  • 43
    • 0013809039 scopus 로고
    • Transport of lysolecithin by albumin in human and rat plasma
    • 5865378
    • Transport of lysolecithin by albumin in human and rat plasma. S Switzer HA Eder, J Lipid Res 1965 6 4 506 511 5865378
    • (1965) J Lipid Res , vol.6 , Issue.4 , pp. 506-511
    • Switzer, S.1    Eder, H.A.2
  • 44
    • 0026596571 scopus 로고
    • Bromcresol green assay is nonspecific for rat plasma albumin
    • 1733318
    • Bromcresol green assay is nonspecific for rat plasma albumin. BJ Barber VL Stanhope, Am J Physiol 1992 262 1 Pt 2 H299 H302 1733318
    • (1992) Am J Physiol , vol.262 , Issue.1 PART 2
    • Barber, B.J.1    Stanhope, V.L.2
  • 45
    • 0038384015 scopus 로고    scopus 로고
    • Acylation of lysophosphatidylcholine plays a key role in the response of monocytes to lipopolysaccharide
    • 10.1046/j.1432-1033.2003.03649.x. 12823548
    • Acylation of lysophosphatidylcholine plays a key role in the response of monocytes to lipopolysaccharide. B Schmid MJ Finnen JL Harwood SK Jackson, Eur J Biochem 2003 270 2782 2788 10.1046/j.1432-1033.2003.03649.x 12823548
    • (2003) Eur J Biochem , vol.270 , pp. 2782-2788
    • Schmid, B.1    Finnen, M.J.2    Harwood, J.L.3    Jackson, S.K.4
  • 46
    • 23944471373 scopus 로고    scopus 로고
    • Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2
    • 16122976
    • Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. W Pruzanski L Lambeau M Lazdunsky W Cho J Kopilov A Kuksis, Biochim Biophys Acta 2005 1736 1 38 50 16122976
    • (2005) Biochim Biophys Acta , vol.1736 , Issue.1 , pp. 38-50
    • Pruzanski, W.1    Lambeau, L.2    Lazdunsky, M.3    Cho, W.4    Kopilov, J.5    Kuksis, A.6
  • 47
  • 48
    • 13444291406 scopus 로고    scopus 로고
    • Paradigm shift in NMDA receptor antagonist drug development: Molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders
    • 15665416
    • Paradigm shift in NMDA receptor antagonist drug development: Molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. SA Lipton, J Alzheimers Dis 2004 6 6 Suppl S61 S74 15665416
    • (2004) J Alzheimers Dis , vol.6 , Issue.6 SUPPL.
    • Lipton, S.A.1
  • 49
    • 0029981211 scopus 로고    scopus 로고
    • Enzyme Inhibition in Open Systems
    • 10.1074/jbc.271.10.5347. 8621387
    • Enzyme Inhibition in Open Systems. AM Westley J Westley, Journal of Biological Chemistry 1996 271 5347 10.1074/jbc.271.10.5347 8621387
    • (1996) Journal of Biological Chemistry , vol.271 , pp. 5347
    • Westley, A.M.1    Westley, J.2
  • 50
    • 0025724884 scopus 로고
    • Interfacial catalysis by phospholipase A2: Determination of the interfacial kinetic rate constants
    • 10.1021/bi00243a034. 1854737
    • Interfacial catalysis by phospholipase A2: determination of the interfacial kinetic rate constants. OG Berg BZ Yu J Rogers MK Jain, Biochemistry 1991 30 7283 7297 10.1021/bi00243a034 1854737
    • (1991) Biochemistry , vol.30 , pp. 7283-7297
    • Berg, O.G.1    Yu, B.Z.2    Rogers, J.3    Jain, M.K.4
  • 51
    • 0032948306 scopus 로고    scopus 로고
    • Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism
    • 10337026. 10.1046/j.1365-2249.1999.00871.x
    • Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. YH Huang L Schafer-Elinder R Wu HE Claesson J Frostegard, Clin Exp Immunol 1999 116 326 331 10337026 10.1046/j.1365-2249.1999.00871.x
    • (1999) Clin Exp Immunol , vol.116 , pp. 326-331
    • Huang, Y.H.1    Schafer-Elinder, L.2    Wu, R.3    Claesson, H.E.4    Frostegard, J.5
  • 52
    • 17144424304 scopus 로고    scopus 로고
    • Phospholipid mediators in the vessel wall: Involvement in atherosclerosis
    • 10.1097/00075197-200503000-00004
    • Phospholipid mediators in the vessel wall: involvement in atherosclerosis. E Ninio, Current Opinion in Clinical Nutrition and Metabolic Care 2005 8 123 10.1097/00075197-200503000-00004
    • (2005) Current Opinion in Clinical Nutrition and Metabolic Care , vol.8 , pp. 123
    • Ninio, E.1
  • 55
    • 0029051953 scopus 로고
    • Arachidonic acid and lysophosphatidylcholine modulate excitatory transmitter amino acid release from the rat cerebral cortex
    • 10.1016/0304-3940(95)11672-J. 7478165
    • Arachidonic acid and lysophosphatidylcholine modulate excitatory transmitter amino acid release from the rat cerebral cortex. MH O'Regan LM Perkins JW Phillis, Neuroscience Letters 1995 193 85 88 10.1016/0304-3940(95) 11672-J 7478165
    • (1995) Neuroscience Letters , vol.193 , pp. 85-88
    • O'Regan, M.H.1    Perkins, L.M.2    Phillis, J.W.3
  • 56
    • 0026725763 scopus 로고
    • Protein kinase C, calcium and phospholipid degradation
    • 10.1016/0968-0004(92)90011-W. 1455509
    • Protein kinase C, calcium and phospholipid degradation. Y Asaoka S Nakamura K Yoshida Y Nishizuka, Trends Biochem Sci 1992 17 414 417 10.1016/0968-0004(92)90011-W 1455509
    • (1992) Trends Biochem Sci , vol.17 , pp. 414-417
    • Asaoka, Y.1    Nakamura, S.2    Yoshida, K.3    Nishizuka, Y.4
  • 57
    • 0028341878 scopus 로고
    • Lipoprotein phospholipid composition and LCAT activity in nephrotic and analbuminemic rats
    • 10.1038/ki.1994.248. 7933850
    • Lipoprotein phospholipid composition and LCAT activity in nephrotic and analbuminemic rats. JA Joles N Willekes-Koolschijn LM Scheek HA Koomans TJ Rabelink A van Tol, Kidney Int 1994 46 97 104 10.1038/ki.1994.248 7933850
    • (1994) Kidney Int , vol.46 , pp. 97-104
    • Joles, J.A.1    Willekes-Koolschijn, N.2    Scheek, L.M.3    Koomans, H.A.4    Rabelink, T.J.5    Van Tol, A.6
  • 58
    • 33846457428 scopus 로고    scopus 로고
    • Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding
    • 10.1016/j.prostaglandins.2006.10.006
    • Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding. YL Kim YJ Im NC Ha DS Im, Prostaglandins and Other Lipid Mediators 2007 83 130 138 10.1016/j.prostaglandins.2006.10.006
    • (2007) Prostaglandins and Other Lipid Mediators , vol.83 , pp. 130-138
    • Kim, Y.L.1    Im, Y.J.2    Ha, N.C.3    Im, D.S.4
  • 59
    • 0015810189 scopus 로고
    • Lysolecithin binding to human and squirrel monkey plasma and tissue components
    • 4127872
    • Lysolecithin binding to human and squirrel monkey plasma and tissue components. OW Portman DR Illingworth, Biochim Biophys Acta 1973 326 34 42 4127872
    • (1973) Biochim Biophys Acta , vol.326 , pp. 34-42
    • Portman, O.W.1    Illingworth, D.R.2
  • 62
    • 18244380087 scopus 로고    scopus 로고
    • Dendritic-cell activation by secretory phospholipase A2
    • 10.1182/blood-2004-08-3001. 15494434
    • Dendritic-cell activation by secretory phospholipase A2. R Ramoner T Putz H Gander A Rahm G Bartsch C Schaber M Thurnher, Blood 2005 105 3583 3587 10.1182/blood-2004-08-3001 15494434
    • (2005) Blood , vol.105 , pp. 3583-3587
    • Ramoner, R.1    Putz, T.2    Gander, H.3    Rahm, A.4    Bartsch, G.5    Schaber, C.6    Thurnher, M.7
  • 63
    • 0037452656 scopus 로고    scopus 로고
    • Sequence similarity in structurally dissimilar proteins
    • 10.1016/S0960-9822(03)00070-8
    • Sequence similarity in structurally dissimilar proteins. S Tomiuk K Hofmann, Current Biology 2003 13 124 125 10.1016/S0960-9822(03)00070-8
    • (2003) Current Biology , vol.13 , pp. 124-125
    • Tomiuk, S.1    Hofmann, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.